check_circleStudy Completed
Contraception
Bayer Identifier:
13871
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
US Ovulation Inhibition Study in Obese Women
Trial purpose
Birth Control Patch Study
Key Participants Requirements
Sex
FemaleAge
18 - 35 YearsTrial summary
Enrollment Goal
173Trial Dates
April 2009 - March 2010Phase
Phase 2Could I Receive a placebo
NoProducts
Gestodene/EE Patch (BAY86-5016)Accepts Healthy Volunteer
YesWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Houston, 77054, United States | |
Completed | San Diego, 92108, United States | |
Completed | Seattle, 98105, United States | |
Completed | Philadelphia, 19114, United States | |
Completed | Sandy Springs, 30328, United States | |
Completed | Tucson, 85712, United States |
Primary Outcome
- Determination of Hoogland Scoresdate_rangeTime Frame:Treatment Cycles 2 & 3enhanced_encryptionnoSafety Issue:
Secondary Outcome
- Laboratory values for E2, progesterone, FSH and LHdate_rangeTime Frame:Pretreatment & regularly during Treatment Cycles 1, 2, 3enhanced_encryptionnoSafety Issue:
- Endometrial thicknessdate_rangeTime Frame:Pretreatment & regularly during Treatment Cycles 1, 2, 3enhanced_encryptionnoSafety Issue:
- Follicle sizedate_rangeTime Frame:Pretreatment & regularly during Treatment Cycles 1, 2, 3enhanced_encryptionnoSafety Issue:
Trial design
Trial Type
InterventionalIntervention Type
DrugTrial Purpose
PreventionAllocation
Non-randomizedBlinding
Open LabelAssignment
Single Group AssignmentTrial Arms
1